Indian equity markets exhibited volatility during the trading week, ultimately concluding with modest gains. The benchmark Nifty 50 index closed at 22,096.75, a gain of 1.2% week-on-week, while the Sensex settled at 73,140.34, up 1.1%. Broad market indices also participated in the rally, with the Nifty Midcap 100 and Nifty Smallcap 100 gaining 1.6% and 2.2% respectively, outperforming the Nifty 50.
Sectoral performance was mixed. Information Technology and Realty emerged as the top performing sectors, gaining 3.1% and 2.8% respectively, driven by positive global cues and renewed optimism regarding housing demand. Conversely, the Nifty Pharma index lagged, declining 1.4% due to profit booking and concerns over US regulatory scrutiny.
According to ICICI Direct, the market is currently in a consolidation phase, with the Nifty expected to trade between 21,800 and 22,300. They advise a cautious approach, suggesting investors maintain a neutral to slightly positive bias. Key support levels for the Nifty are identified at 21,850 and 21,600, while resistance is seen at 22,200 and 22,500. A decisive move above 22,500 could trigger further upside, while a breach of 21,600 might indicate a potential correction.
FII and DII Activity
Foreign Institutional Investors (FIIs) remained net buyers during the week, adding ₹14,455 crore to their equity holdings. Domestic Institutional Investors (DIIs), however, were net sellers, offloading ₹4,114 crore. The continued inflow from FIIs is a positive sign, indicating confidence in the Indian economy and equity markets. However, DII selling needs to be monitored as it could potentially offset FII buying.
ICICI Direct highlights several key stocks for the week. Among the large-cap recommendations, they suggest a ‘Buy’ rating for HDFC Bank with a target price of ₹1,950, citing strong fundamentals and attractive valuations. For ITC, they maintain a ‘Buy’ recommendation with a target of ₹450, anticipating continued growth in the FMCG segment. In the mid-cap space, they favor Apollo Hospitals with a target price of ₹5,400, driven by the increasing demand for healthcare services.
On the technical front, ICICI Direct recommends focusing on stocks exhibiting strong momentum and positive price action. They advise investors to adopt a stock-specific approach, carefully evaluating the risk-reward ratio before making any investment decisions. They also emphasize the importance of maintaining proper risk management strategies, including setting stop-loss levels to protect profits and limit potential losses.
Global markets remained largely positive, supported by encouraging economic data from the US and China. However, geopolitical tensions and concerns over rising interest rates continue to pose risks. ICICI Direct believes that the Indian market is relatively well-positioned to weather these challenges, given its strong economic growth and improving corporate earnings. Investors are advised to remain vigilant and monitor global developments closely.
Overall, ICICI Direct’s outlook for the Indian equity market remains cautiously optimistic. They expect the market to continue its upward trajectory in the long term, but caution against excessive exuberance in the short term. A disciplined investment approach, coupled with a focus on fundamentally strong stocks, is recommended to navigate the current market environment.
Image Source: Google | Image Credit: Respective Owner
